Starting in 2026, the Central Board of Secondary Education (CBSE) will roll out Class 10 board examinations twice a year. T..|News Track ...

In recent times, there have been two major mission failures for ISRO -- in 2022, the first flight of the Small Satellite ...

The proposed changes were thoroughly reviewed and will be reportedly opened for public consultation next Monday.

Novartis exceeds Q4 2024 expectations with 16% sales growth, strong EPS trajectory, and strategic R&D investments. Read why ...

The easiest way to invest in a diversified basket of European equities is via a mutual fund or exchange-traded fund that is indexed to that region's stock market. The U.S.-based ETF benchmarked to ...

Ianalumab, for the treatment of primary immune thrombocytopenia, was granted FDA orphan designation, according to a post on the ...

From KNX Association’s point of view, ISE 2025 kicked off with an impressive start, drawing in a diverse crowd from across ...

Novartis is acquiring Anthos Therapeutics for up to $3.08 billion, adding abelacimab, a late-stage anticoagulant, to its ...

In his next chief executive gig after securing the $14 billion acquisition of Karuna Therapeutics Inc., Bill Meury has now ...

ISRO's NVS-02 satellite fails to reach geostationary orbit due to valve failure, impacting NavIC and Gaganyaan missions.

Ads from Anheuser-Busch attracted acclaim to the beer-maker's marketing pitches on a day of star-studded—and expensive—advertisements.